Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Cancer Stage II-III”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT03815890
What this trial is testing

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 80
Large-scale testing (Phase 3)Ended earlyNCT00089141
What this trial is testing

Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD)

Who this might be right for
Cancer
Martin, Paul 151
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00136539
What this trial is testing

Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

Who this might be right for
Breast Cancer
Harold J. Burstein, MD, PhD 41
Testing effectiveness (Phase 2)Study completedNCT00078845
What this trial is testing

Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors

Who this might be right for
Breast CancerLung CancerNeurotoxicity+3 more
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00004175
What this trial is testing

Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Stage III Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University
Early research (Phase 1)Study completedNCT00003107
What this trial is testing

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+8 more
Indiana University
Not applicableEnded earlyNCT01050075
What this trial is testing

Acupuncture in Treating Nerve Pain in Patients With Stage I, Stage II, or Stage III Breast Cancer Who Are Receiving Paclitaxel

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+3 more
City of Hope Medical Center 7
Not applicableLooking for participantsNCT06905301
What this trial is testing

Implementation Study to Describe and Compare Retention Rate and Adherence to Adjuvant Therapy With Ribociclib With and Without Usage of Mobile Application in Patients With HR+ HER2-negative Stage II and III Breast Cancer in Real-world Practice

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 240
Testing effectiveness (Phase 2)Looking for participantsNCT07460752
What this trial is testing

Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
Mayo Clinic 98
Large-scale testing (Phase 3)Active Not RecruitingNCT02445391
What this trial is testing

Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy

Who this might be right for
Estrogen Receptor NegativeHER2/Neu NegativeInvasive Breast Carcinoma+9 more
ECOG-ACRIN Cancer Research Group 415
Large-scale testing (Phase 3)Looking for participantsNCT07294508
What this trial is testing

Evaluate HLX22 in Combination With HLX87 in Patients With HER2-Positive Recurrent or Metastatic Breast Cancer

Who this might be right for
HER2 + Breast Cancer
Shanghai Henlius Biotech 706
Testing effectiveness (Phase 2)Looking for participantsNCT07191717
What this trial is testing

Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+3 more
Jonsson Comprehensive Cancer Center 42
Testing effectiveness (Phase 2)Study completedNCT01764802
What this trial is testing

Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer

Who this might be right for
Ovarian SarcomaOvarian Stromal CancerStage I Uterine Sarcoma+59 more
Ohio State University Comprehensive Cancer Center 100
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00002679
What this trial is testing

Adjuvant High-Dose, Sequential Chemotherapy in Treating Patients With Resected Breast Cancer

Who this might be right for
Breast Cancer
Yale University 89
Not applicableLooking for participantsNCT06930859
What this trial is testing

Non-interventional Study to Assess the Effectiveness and Safety of Ribociclib in the Adjuvant Therapy of Hormone Receptor Positive (HR+) HER2-negative Stage II and III Breast Cancer in Real Clinical Practice in Russia

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 2,766
Testing effectiveness (Phase 2)Ended earlyNCT02096588
What this trial is testing

Detection and Prevention of Anthracycline-Related Cardiac Toxicity With Concurrent Simvastatin

Who this might be right for
Breast CancerStage I Breast CancerStage II Breast Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 34
Not applicableStudy completedNCT00090974
What this trial is testing

Quality of Life in Postmenopausal Women Who Are Receiving Either Exemestane or Anastrozole With or Without Celecoxib for Stage I, Stage II, or Stage IIIA Primary Breast Cancer

Who this might be right for
Breast Cancer
Eastern Cooperative Oncology Group
Large-scale testing (Phase 3)Active Not RecruitingNCT02750826
What this trial is testing

Breast Cancer WEight Loss Study (BWEL Study)

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaStage II Breast Cancer AJCC v6 and v7+4 more
Alliance for Clinical Trials in Oncology 3,177
Next Page